CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
galy A Plus +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01244529
NCT01244529N/ACompleted
CompareCT.gov

Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens Wearers

Johnson & Johnson Vision Care, Inc.·interventional·Posted Nov 19, 2010·Updated Jun 19, 2018

In Brief

A clinical study evaluating galy A Plus, seno A, and 1 other intervention for Myopia. Completed, enrolled 41 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the comparability of lens fit and lens power of a new contact lens to the lens fit and lens power of two marketed lenses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2010
Enrollment StartSep 1, 2010
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.6 years ago

Interventions

galy A Plusdevice

galyfilcon A Plus, BC: 8.3 or 8.7

seno Adevice

senofilcon A, BC:8.4 or 8.8

galy Adevice

galyfilcon A , BC: 8.3 or 8.7